Personal tools

Coexpression cluster:C1320

From FANTOM5_SSTAR

Revision as of 11:08, 19 October 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1320_Neutrophils_Eosinophils_CD14_Natural_Peripheral_Basophils_CD8



Phase1 CAGE Peaks

Hg19::chr10:70849864..70849882,-p@chr10:70849864..70849882
-
Hg19::chr12:19593186..19593212,-p@chr12:19593186..19593212
-
Hg19::chr15:79165517..79165535,-p@chr15:79165517..79165535
-
Hg19::chr17:36981699..36981722,+p2@MIR4727
Hg19::chr19:13957456..13957468,-p@chr19:13957456..13957468
-
Hg19::chrX:70331529..70331558,+p@chrX:70331529..70331558
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
leukocyte1.93e-66136
hematopoietic stem cell5.46e-57168
angioblastic mesenchymal cell5.46e-57168
hematopoietic cell6.76e-55177
hematopoietic oligopotent progenitor cell5.84e-52161
hematopoietic multipotent progenitor cell5.84e-52161
hematopoietic lineage restricted progenitor cell1.91e-51120
nongranular leukocyte2.67e-50115
classical monocyte1.53e-4542
CD14-positive, CD16-negative classical monocyte1.53e-4542
myeloid leukocyte3.65e-4072
defensive cell1.05e-3748
phagocyte1.05e-3748
granulocyte monocyte progenitor cell3.37e-3267
myeloid cell2.19e-31108
common myeloid progenitor2.19e-31108
macrophage dendritic cell progenitor4.70e-3061
myeloid lineage restricted progenitor cell8.40e-3066
monopoietic cell2.17e-2859
monocyte2.17e-2859
monoblast2.17e-2859
promonocyte2.17e-2859
lymphoid lineage restricted progenitor cell1.12e-1852
lymphocyte4.29e-1853
common lymphoid progenitor4.29e-1853
nucleate cell5.33e-1755
stuff accumulating cell1.34e-1487
mesenchymal cell7.22e-14354
connective tissue cell5.53e-13361
motile cell1.68e-11386
granulocyte3.70e-118
T cell4.23e-1125
pro-T cell4.23e-1125
intermediate monocyte5.01e-119
CD14-positive, CD16-positive monocyte5.01e-119
mature alpha-beta T cell1.23e-1018
alpha-beta T cell1.23e-1018
immature T cell1.23e-1018
mature T cell1.23e-1018
immature alpha-beta T cell1.23e-1018
blood cell2.33e-0911
stem cell3.59e-09441
multi fate stem cell1.91e-08427
CD4-positive, alpha-beta T cell5.28e-086
somatic stem cell6.31e-08433
Uber Anatomy
Ontology termp-valuen
hematopoietic system3.13e-3998
blood island3.13e-3998
hemolymphoid system1.56e-34108
bone marrow1.27e-2776
immune system1.49e-2693
bone element2.68e-2482
skeletal element1.35e-2090
skeletal system8.96e-18100
connective tissue3.28e-12371
lateral plate mesoderm3.61e-11203
blood4.22e-0915
haemolymphatic fluid4.22e-0915
organism substance4.22e-0915


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BRF2#552901179.0959302325580.005570700836719840.0252089962600712
MEF2C#4208213.77045149754130.008235596942270060.0324633896604545
NFKB1#479043.658708949462560.01207927289015230.0438204585562061
POLR2A#543062.147453176558070.01019570676818780.0379889196989927
TBP#690853.088975572580320.006645448275786930.028279845671702
XRCC4#75181716.3837209302320.001395107170798050.00907867143192582
YY1#752854.092642291544880.001743365462849530.0107229296569224



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.